There are 2934 resources available
Proffered Paper 1 - NSCLC, metastatic - Invited Discussant 1478O and 1479O
Presenter: Lizza Hendriks
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Slides
Webcast
Proffered Paper 1 - NSCLC, metastatic - Invited Discussant LBA79 and LBA80
Presenter: Naiyer Rizvi
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Slides
Webcast
4884 - Results of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain
Presenter: Laura Chow
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
2693 - Integrated Genomic and DNA Methylation Analyses of Non-Small Cell Lung Cancer Patients with Brain Metastases
Presenter: Yanjun Xu
Session: Proffered Paper 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
How to select patients for immunotherapy doublet
Presenter: Camillo Guglielmo Porta
Session: Frontline in mRCC: Ready to select treatment?
Resources:
Slides
Webcast
How to select patients for immunotherapy + VEGF inhibition
Presenter: Laurence Albiges
Session: Frontline in mRCC: Ready to select treatment?
Resources:
Slides
Webcast
Biomarker in RCC: Clinical perspective
Presenter: Toni Choueiri
Session: Frontline in mRCC: Ready to select treatment?
Resources:
Slides
Webcast
Introduction
Presenter: Iain Hagan
Session: Innate immune system and anti-mitotic agents: Two fields getting together
Resources:
Slides
Webcast
Chromosome mis-segregation in cancer
Presenter: Hiro Funabiki
Session: Innate immune system and anti-mitotic agents: Two fields getting together
Resources:
Slides
Webcast
TGFb and PD1: The relevance of tumour associated macrophages
Presenter: Thomas Powles
Session: Innate immune system and anti-mitotic agents: Two fields getting together
Resources:
Slides
Webcast